News | April 19, 2007

Interventional Cardiology Device Market Climbs From Late-’06 Dip

April 20, 2007 — The U.S. interventional cardiology market value increased 1.5 percent in Q1 2007 over Q4 2006, according to Millennium Research Group's (MRG) Marketrack service.

Coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloons, intravascular ultrasound (IVUS) catheters, thrombectomy devices and atheterectomy devices all grew in market value after a slow December in 2006.

"In December we saw percutaneous coronary intervention (PCI) procedures and revenues on the decline, but it seems that this past quarter has shown an increase," say Bina Mistry, analyst at MRG. "Risks associating drug coated stents with late stent thrombosis slowed down procedure volumes in December. In Q1 2007, however, PCI procedures increased with less hesitation by physicians to perform this treatment option. Moreover, an increase in PTCA balloon, thrombectomy, and atherectomy procedures was also noticed - such procedures can replace stent procedures in patients suffering from coronary artery disease (CAD).

Additionally, screening initiatives through diagnostic angiographies has increased in Q1 2007 over Q1 2006. As a result, diagnostic catheters, which facilitate the diagnosis of CAD during this procedure, experienced increased unit sales translating into a market increase of 47 percent in Q1 2007 compared to Q1 2006.

Interventional Cardiology Marketrack gathers data from over 140 cath labs throughout the US on a monthly basis. Product categories covered include drug-eluting coronary stents, bare-metal coronary stents, PTCA balloons, guide wires, guiding catheters, diagnostic catheters, embolic protection devices, IVUS catheters, introducer sheaths, atherectomy devices, thrombectomy devices, inflation devices and vascular closure devices. MRG also gathers data from Europe, Japan, Asia Pacific, Latin America and the Middle East. Marketrack subscribers receive thousands of data points, including usage (units, average selling price, and revenue), procedure, competitor, and brand information.

For more information visit www.MRG.net.


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now